Zobrazeno 1 - 7
of 7
pro vyhledávání: '"A E, Awrich"'
Publikováno v:
Journal of Surgical Oncology. 17:321-326
Four patients with metastatic glucagonoma and one patient with metastatic diarrheogenic islet cell carcinoma of the pancreas were treated with dimethyltriazenoimidazole carboxamide (DTIC), 250 mg/M2 daily for five days repeated every four weeks. All
Publikováno v:
The American Journal of Surgery. 152:70-74
The syndrome of intrahepatic inferior vena cava obstruction has neither been commonly recognized nor adequately described. Symptoms include the abrupt onset of ascites, hepatomegaly, and fluid retention below the diaphragm with edema of the lower ext
Publikováno v:
The Journal of Pediatrics. 87:731-738
A 9-year-old girl with hereditary dibasicaminoaciduria has been studied for three years. Initially, clinical features were: growth failure; anorexia and aversion to protein, spontaneous daily protein intake averaging only 10 gm; fasting and postprand
Publikováno v:
Surgery, gynecologyobstetrics. 151(1)
Autor:
William S. Fletcher, Alan E. Awrich, Michael E. Peetz, Edward J. Keenan, Charlene E. Davenport, H.Stephens Moseley
Publikováno v:
American journal of surgery. 141(5)
The records of 204 women with metastatic breast carcinoma treated by oophorectomy were analyzed. Premenopausal women had a response rate of 50 percent. Forty-one percent of postmenopausal women responded. Those who responded had an average duration o
Publikováno v:
American journal of surgery. 140(1)
Steroid hormone receptors are currently the key to selecting patients who might benefit from endocrine manipulation. As knowledge of the interaction between the various receptors in the cytoplasm and nucleus increases, it is hoped that the percentage
Autor:
Alan E. Awrich, John P. Minton, Jerome H. Klotz, George J. Hill, William S. Fletcher, Phyllis M. Multhauf, Theodor B. Grage, J. Bradley Aust
Publikováno v:
Journal of surgical oncology. 12(3)
From May 1972 until May 1976, 105 patients were entered on Central Oncology Group protocol 7230 to compare the combination of streptozotocin, tubercidin, and 5-fluorouracil (5-FU) versus 5-FU alone in the treatment of adenocarcinoma and islet cell ca